Evidence map›Paper›PMID 31795161›Full record

ReviewInternational journal of molecular sciences2019

Deubiquitinating Enzymes: A Critical Regulator of Mitosis.

Jinyoung Park, Jinhong Cho, Eunice EunKyeong Kim, Eun Joo Song

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. USP40 protects podocytes by deubiquitylating integrin β1.Biochemical and biophysical research communications · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Regulation of Deubiquitinating Enzymes by Post-Translational Modifications.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jinyoung ParkMolecular Recognition Research Center, Korea Institute of Science and Technology, Seoul 02792, Korea.
Jinhong ChoBiomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea.
Eunice EunKyeong KimBiomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea.
Eun Joo SongGraduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 03760, Korea.ORCID 0000-0002-2420-6666

Funding

National Research Foundation of Korea 2019R1A2C2004052 and 2017R1A2B3007224R&D Convergence Program of National Research Council of Science & Technology of Korea CAP-16-03-KRIBB
6 · The paper itself

Abstract

Mitosis is a complex and dynamic process that is tightly regulated by a large number of mitotic proteins. Dysregulation of these proteins can generate daughter cells that exhibit genomic instability and aneuploidy, and such cells can transform into tumorigenic cells. Thus, it is important for faithful mitotic progression to regulate mitotic proteins at specific locations in the cells at a given time in each phase of mitosis. Ubiquitin-dependent modifications play critical roles in this process by regulating the degradation, translocation, or signal transduction of mitotic proteins. Here, we review how ubiquitination and deubiquitination regulate the progression of mitosis. In addition, we summarize the substrates and roles of some deubiquitinating enzymes (DUBs) crucial for mitosis and describe how they contribute error correction during mitosis and control the transition between the mitotic phases.

Indexed as

MitosisAnimalsDeubiquitinating EnzymesHumansUbiquitinationUbiquitin-Protein LigasesDeubiquitinating EnzymesUbiquitin-Protein Ligasescancerdeubiquitinationmitosisubiquitination

Identifiers

PMID31795161
PMCPMC6929034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.